State Pharmacist Associations Begin Medication Adherence Projects
The Alliance for Patient Medication Safety (APMS), a supporting organization of the National Alliance of State
Pharmacy Associations (NASPA), announces six discovery projects that will identify ways in which pharmacists
can assist patients improve medication adherence. This activity is intended to produce measurable,
replicable and sustainable programs in community pharmacy to improve adherence or methods to identify
non-adherent patients. The Adherence Discovery Projects are designed to be conducted over a six-month
period beginning January 2011. The projects approach improving adherence in a variety of ways and many
incorporated adherence measures from the Pharmacy Quality Alliance. The projects include:
1. The Arizona Pharmacy Alliance will oversee an adherence team, comprised of pharmacists,
behavioral health specialists and community health advisors, to improve outcomes for underserved patients in
Tucson, AZ. The specific aims are to examine the effectiveness of the team on improving adherence, conduct an
evaluation of the team concept from both the provider and patient perspective, and examine potential for
expanding collaboration to the community at large.
2. The Connecticut Pharmacists Association along with Arrow Pharmacy in Hartford, CT will use
motivational interviewing techniques/skills to probe and identify reasons for patients not picking up
medications. Based on assessment of patient responses, the pharmacist will recommend one or more
interventions such as referring the patient to a PharmNetEx (a subsidiary of the Connecticut Pharmacists
Association) pharmacist for comprehensive MTM evaluation, enrolling the patient to receive refill reminder calls,
or recommending follow up with the prescriber.
3. The Iowa Pharmacy Association will use pharmacists from CarePro Health Services and
other pharmacies that have been trained as health coaches through an application-based continuing pharmacy
education activity. They will work to demonstrate improvements in medication adherence through a
health coach intervention. This project will serve as a pilot project to further advance the role of pharmacists as
health coaches, particularly to improve quality measures and enhance medication therapy management
4. The Massachusetts Pharmacists Association along with Allen’s Pharmacy in Manchester, MA will provide
an adherence service consisting of an electronic closure which allows the patient or caregiver to program it to
provide an audio and visual alert to remind them that the next dose of a medication is due, as well as a
counseling session to patients on the use of the device and the importance of medication adherence.
5. The Virginia Pharmacists Association along with SuperioRx Care in Richmond, VA will use a collaborative
model of pharmacist-to-pharmacist interaction between the primary care office and the community pharmacy. The
proposal addresses multiple factors related to poor adherence with statins, including promotion of timely follow-up
and education regarding adverse effects and lifestyle changes. A project of this type also promotes the
development of the role of a pharmacist in a primary care site where pharmacist integration into the
Patient-Centered Medical Home model is desired.
6. The Pharmacy Society of Wisconsin will distribute a pharmacy practice tool to assist pharmacists and
patients in clearly identifying barriers to adherence and discuss possible strategies that will work best for each
patient. The tool which is a pocket-size, fold-out card, can be used as a resource for pharmacists during regular
patient consultations or during comprehensive medication reviews. The goals are to increase patient
understanding of barriers to adherence, to increase patient adherence to prescribed medications, and to assist
pharmacists in facilitating this process with their patients.
BeMedWise Program at NeedyMeds encourages healthcare professionals and community groups to foster patient–professional communication about medicines. However, BeMedWise does not supervise or endorse the activities of any group or professional. Discussion and action concerning medicines are solely the responsibility of the patient and their healthcare professionals, and not BeMedWise.
Please consult a licensed health care professional with questions or concerns about your medication and/or condition.